These experiments further demonstrate how the biological activity of the exosomal lncRNA PSMA3-AS1 can be transmitted between different cell types, affecting cell function, and may serve as a therapeutic target for MM bone lesions. Here, PSMA3 is linked to Miyoshi myopathy.